Cargando…

Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2

Emerging evidences have indicated that long non-coding RNAs (lncRNAs) are pivotal regulators of tumor development and progression. HNF1A-AS1 (HNF1A antisense RNA 1, C12 or f27) is a novel long non-coding RNA that acts as a potential biomarker and is involved in development and progression of several...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Yonghao, Li, Yifan, Guan, Bao, Wang, Zicheng, Peng, Ding, Chen, Zhicong, He, Anbang, He, Shiming, Gong, Yanqing, Li, Xuesong, Zhou, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652733/ https://www.ncbi.nlm.nih.gov/pubmed/29100339 http://dx.doi.org/10.18632/oncotarget.20795

Ejemplares similares

Prognostic value of long non-coding RNA signatures in bladder cancer
por: He, Anbang, et al.
Publicado: (2019)

Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA
por: Zhan, Yonghao, et al.
Publicado: (2018)

Correction: Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA
por: Zhan, Yonghao, et al.
Publicado: (2023)

Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
por: Zhan, Yonghao, et al.
Publicado: (2020)

Correction: Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
por: Zhan, Yonghao, et al.
Publicado: (2023)

Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2017)

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2023)

TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation
por: Chen, Zhicong, et al.
Publicado: (2019)

High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese center
por: Li, Yifan, et al.
Publicado: (2019)

MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
por: He, Anbang, et al.
Publicado: (2020)

P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma
por: Wu, Yucai, et al.
Publicado: (2021)

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2020)

Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer
por: Lin, Junhao, et al.
Publicado: (2017)

Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer
por: Wu, Yucai, et al.
Publicado: (2020)

Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis
por: Chen, Zhicong, et al.
Publicado: (2018)

ZFAS1: A novel vital oncogenic lncRNA in multiple human cancers
por: He, Anbang, et al.
Publicado: (2018)

Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer
por: Peng, Ding, et al.
Publicado: (2018)

Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer
por: Li, Jianfa, et al.
Publicado: (2016)

Upregulation of ATP Binding Cassette Subfamily C Member 5 facilitates Prostate Cancer progression and Enzalutamide resistance via the CDK1-mediated AR Ser81 Phosphorylation Pathway
por: Ji, Guangjie, et al.
Publicado: (2021)

Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer
por: Li, Jianfa, et al.
Publicado: (2023)

Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2016)

Increased Expression Of SOX2 Predicts A Poor Prognosis And Promotes Malignant Phenotypes In Upper Tract Urothelial Carcinoma
por: Bao, Zhengqing, et al.
Publicado: (2019)

Correction: Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2023)

Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2023)

Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma
por: Guan, Bao, et al.
Publicado: (2018)

Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells
por: Chen, Zhicong, et al.
Publicado: (2016)

Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer
por: He, Anbang, et al.
Publicado: (2016)

Recent development on synthetic biological devices treating bladder cancer
por: Chen, Zhicong, et al.
Publicado: (2016)

MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma
por: Li, Yifan, et al.
Publicado: (2019)

AB169. CCDC34 is up-regulated in bladder cancer and its silencing suppresses bladder cancer cell proliferation and migration
por: Gong, Yanqing, et al.
Publicado: (2015)

EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
por: Wang, Anbang, et al.
Publicado: (2020)

Ascorbic acid induced TET2 enzyme activation enhances cancer immunotherapy efficacy in renal cell carcinoma
por: Peng, Ding, et al.
Publicado: (2022)

The Roles of Long Noncoding RNAs HNF1α-AS1 and HNF4α-AS1 in Drug Metabolism and Human Diseases
por: Chen, Liming, et al.
Publicado: (2020)

shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells
por: Li, Jianfa, et al.
Publicado: (2016)

Species-Specific Differences in the Expression of the HNF1A, HNF1B and HNF4A Genes
por: Harries, Lorna W., et al.
Publicado: (2009)

Increased phosphorylated CREB1 protein correlates with poor prognosis in clear cell renal cell carcinoma
por: Zhang, Zhongyuan, et al.
Publicado: (2021)

Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis
por: Li, Yifan, et al.
Publicado: (2018)

Targeting cellular mRNAs translation by CRISPR-Cas9
por: Liu, Yuchen, et al.
Publicado: (2016)

Comprehensive analysis of m6A regulators prognostic value in prostate cancer
por: Ji, Guangjie, et al.
Publicado: (2020)

LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells
por: Xie, Haibiao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5di6fvhd8rec8rqk3f1ninlrhh